Mariana Oliveira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mariana Oliveira has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Belkis Menaa
Laboratory of Applied Biochemistry and Microbiology, Badji Mokhtar-Annaba University, Annaba, Algeria
2 shared publications - Cristina Veríssimo
Department of Infectious Diseases, National Institute of Health Doctor Ricardo Jorge, Lisbon, Portugal
2 shared publications Djamel Chekireb
Laboratory of Applied Biochemistry and Microbiology, Badji Mokhtar-Annaba University, Annaba, Algeria
2 shared publications- Helena Simões
Reference Unit for Parasitic and Fungal Infections, Department of Infectious Diseases, National Institute of Health, Dr. Ricardo Jorge, 1649-016 Lisbon, Portugal
2 shared publications - Inês Ribeiro
CIIMAR- Interdisciplinary Centre of Marine and Environmental Research, University of Porto, Porto, Portugal
2 shared publications - Maria de Fatima Carvalho
Interdisciplinary Centre of Marine and Environmental Research (CIIMAR), Terminal de Cruzeiros do Porto de Leixões, Av. General Norton de Matos, s/n, 4450-208 Porto, Portugal
2 shared publications
Latest Publications
- 14 October 2025
- Published by Springer Nature in Brazilian Journal of Microbiology
- Vol. 56 (4) , 2347-2361
Isolation and characterization of endophytic actinobacteria associated with Artemisia judaica L. ssp. sahariensis from desert regions in Algeria
Endophytic actinobacteria, known for symbiotic relationships with plants and production of bioactive compounds, occur in diverse environments, including deserts. The Sahara’s nutrient scarcity, high temperatures, and salinity drive unique microbial adaptations, making it a promising reservoir of novel taxa. This study reports, for the first time, the isolation and characterization of endophytic actinobacteria from Artemisia judaica L. ssp. sahariensis, a medicinal plant of the Algerian desert. Forty-two actinobacterial isolates were obtained from root and leaf tissues and identified through 16 S rRNA gene sequencing, revealing their affiliation with five genera: Micromonospora, Nonomuraea, Nocardiopsis, Gordonia, and predominantly Streptomyces. These isolates were characterized for morphological, physiological, and bioactive traits, including stress tolerance, phosphate solubilization, extracellular enzyme production, and antibacterial activity. More than 93% exhibited antagonistic effects against at least one tested pathogen. The most active strains showed minimum inhibitory concentration values between 4 and 8 µg/mL, highlighting their strong antibacterial potential. All isolates tolerated up to 5% NaCl, and several, including AJR36, AJR38, and AJR16, grew at 15%. Phosphate solubilization was observed in 36% of isolates, while 38% displayed diverse enzymatic activities. Although this study focused on a single plant species, the observed functional diversity underscores the biotechnological potential of these desert-associated endophytes. These findings suggest that unexplored desert ecosystems harbor valuable Actinomycetota resources, supporting further investigations for the discovery of novel species and their potential applications in agriculture and medicine.
- 14 October 2025
- Published by Springer Nature in Brazilian Journal of Microbiology
- Vol. 56 (4) , 2347-2361
Isolation and characterization of endophytic actinobacteria associated with Artemisia judaica L. ssp. sahariensis from desert regions in Algeria
Endophytic actinobacteria, known for symbiotic relationships with plants and production of bioactive compounds, occur in diverse environments, including deserts. The Sahara’s nutrient scarcity, high temperatures, and salinity drive unique microbial adaptations, making it a promising reservoir of novel taxa. This study reports, for the first time, the isolation and characterization of endophytic actinobacteria from Artemisia judaica L. ssp. sahariensis, a medicinal plant of the Algerian desert. Forty-two actinobacterial isolates were obtained from root and leaf tissues and identified through 16 S rRNA gene sequencing, revealing their affiliation with five genera: Micromonospora, Nonomuraea, Nocardiopsis, Gordonia, and predominantly Streptomyces. These isolates were characterized for morphological, physiological, and bioactive traits, including stress tolerance, phosphate solubilization, extracellular enzyme production, and antibacterial activity. More than 93% exhibited antagonistic effects against at least one tested pathogen. The most active strains showed minimum inhibitory concentration values between 4 and 8 µg/mL, highlighting their strong antibacterial potential. All isolates tolerated up to 5% NaCl, and several, including AJR36, AJR38, and AJR16, grew at 15%. Phosphate solubilization was observed in 36% of isolates, while 38% displayed diverse enzymatic activities. Although this study focused on a single plant species, the observed functional diversity underscores the biotechnological potential of these desert-associated endophytes. These findings suggest that unexplored desert ecosystems harbor valuable Actinomycetota resources, supporting further investigations for the discovery of novel species and their potential applications in agriculture and medicine.
- 17 September 2025
- Published by Springer Nature in Biologia
- Vol. 80 (10) , 2927-2943
Diversity and antibacterial activity of endophytic Streptomyces isolated from Artemisia spp. in Algerian extreme habitats
- 17 September 2025
- Published by Springer Nature in Biologia
- Vol. 80 (10) , 2927-2943
Diversity and antibacterial activity of endophytic Streptomyces isolated from Artemisia spp. in Algerian extreme habitats
- Open Access
- 11 November 2022
- Published by Elsevier in Infectious Diseases Now
- Vol. 53 (2) , 104633
Molecular detection of Aspergillus in respiratory samples collected from patients at higher risk of chronic pulmonary aspergillosis
- 11 November 2022
- Published by Elsevier in Infectious Diseases Now
- Vol. 53 (2) , 104633
Open AccessMolecular detection of Aspergillus in respiratory samples collected from patients at higher risk of chronic pulmonary aspergillosis
- Open Access
- 6 January 2021
- Published by MDPI AG in Journal of Fungi
- Vol. 7 (1) , 28
Trends on Aspergillus Epidemiology—Perspectives from a National Reference Laboratory Surveillance Program
Identification of Aspergillus to species level is important since sibling species may display variable susceptibilities to multiple antifungal drugs and also because correct identification contributes to improve the knowledge of epidemiological studies. Two retrospective laboratory studies were conducted on Aspergillus surveillance at the Portuguese National Mycology Reference Laboratory. The first, covering the period 2017–2018, aimed to study the molecular epidemiology of 256 Aspergillus isolates obtained from patients with respiratory, subcutaneous, or systemic infections and from environmental samples. The second, using our entire collection of clinical and environmental A. fumigatus isolates (N = 337), collected between 2012 and 2019, aimed to determine the frequency of azole-resistant A. fumigatus isolates. Aspergillus fumigatus sensu stricto was the most frequent species in both clinical and environmental samples. Overall, and considering all Aspergillus sections identified, a high frequency of cryptic species was detected, based on beta-tubulin or calmodulin sequencing (37% in clinical and 51% in environmental isolates). Regarding all Fumigati isolates recovered from 2012–2019, the frequency of cryptic species was 5.3% (18/337), with the identification of A. felis (complex), A. lentulus, A. udagawae, A. hiratsukae, and A. oerlinghauensis. To determine the frequency of azole resistance of A. fumigatus, isolates were screened for azole resistance using azole-agars, and 53 possible resistant isolates were tested by the CLSI microdilution reference method. Nine A. fumigatus sensu stricto and six Fumigati cryptic isolates showed high minimal inhibitory concentrations to itraconazole, voriconazole, and/or posaconazole. Real-time PCR to detect cyp51A mutations and sequencing of cyp51A gene and its promoter were performed. The overall frequency of resistance to azoles in A. fumigatus sensu stricto was 3.0%. With this retrospective analysis, we were able to detect one azole-resistant G54R mutant A. fumigatus environmental isolate, collected in 2015. The TR34/L98H mutation, linked to environmental transmission route of azole resistance, was the most frequently detected mutation (N = 4; 1.4%). Our findings underline the demand for correct identification and susceptibility testing of Aspergillus isolates.
- 6 January 2021
- Published by MDPI AG in Journal of Fungi
- Vol. 7 (1) , 28
Open AccessTrends on Aspergillus Epidemiology—Perspectives from a National Reference Laboratory Surveillance Program
Identification of Aspergillus to species level is important since sibling species may display variable susceptibilities to multiple antifungal drugs and also because correct identification contributes to improve the knowledge of epidemiological studies. Two retrospective laboratory studies were conducted on Aspergillus surveillance at the Portuguese National Mycology Reference Laboratory. The first, covering the period 2017–2018, aimed to study the molecular epidemiology of 256 Aspergillus isolates obtained from patients with respiratory, subcutaneous, or systemic infections and from environmental samples. The second, using our entire collection of clinical and environmental A. fumigatus isolates (N = 337), collected between 2012 and 2019, aimed to determine the frequency of azole-resistant A. fumigatus isolates. Aspergillus fumigatus sensu stricto was the most frequent species in both clinical and environmental samples. Overall, and considering all Aspergillus sections identified, a high frequency of cryptic species was detected, based on beta-tubulin or calmodulin sequencing (37% in clinical and 51% in environmental isolates). Regarding all Fumigati isolates recovered from 2012–2019, the frequency of cryptic species was 5.3% (18/337), with the identification of A. felis (complex), A. lentulus, A. udagawae, A. hiratsukae, and A. oerlinghauensis. To determine the frequency of azole resistance of A. fumigatus, isolates were screened for azole resistance using azole-agars, and 53 possible resistant isolates were tested by the CLSI microdilution reference method. Nine A. fumigatus sensu stricto and six Fumigati cryptic isolates showed high minimal inhibitory concentrations to itraconazole, voriconazole, and/or posaconazole. Real-time PCR to detect cyp51A mutations and sequencing of cyp51A gene and its promoter were performed. The overall frequency of resistance to azoles in A. fumigatus sensu stricto was 3.0%. With this retrospective analysis, we were able to detect one azole-resistant G54R mutant A. fumigatus environmental isolate, collected in 2015. The TR34/L98H mutation, linked to environmental transmission route of azole resistance, was the most frequently detected mutation (N = 4; 1.4%). Our findings underline the demand for correct identification and susceptibility testing of Aspergillus isolates.
- Open Access
Occurrence of Mycotoxins in Fish Feed and Its Effects: A Review
Plant-based ingredients have been successfully replacing fishmeal in finished fish feeds. However, using crops in feeds results in an increased risk of contamination by fungi and mycotoxins and a higher incidence of mycotoxicosis in fish. This might decrease aquaculture’s productivity as mycotoxicosis generally result in decreased body weight, growth impairment and higher rates of disease and mortality in fish. Additionally, some mycotoxins might accumulate in the fish musculature. As such, fish consumption might become another way for mycotoxins to enter the human food chain, threatening food security and public health as mycotoxins are important genotoxins, carcinogens and immunosuppressors to humans. In this work we aim to provide a review on the most important mycotoxins found in crops and in finished fish feed, i.e., aflatoxins, fumonisins, ochratoxins, trichothecenes and zearalenone. We present their effects on the health of fish and humans and their regulations in the European Union. Although work has been performed in mycotoxin research ever since the 1960s, a lot of information is still lacking regarding its effects. However, it is noticed that in order to use crops in aquafeed production, efforts should be made in order to monitor its contamination by mycotoxinogenic fungi and mycotoxins.
Open AccessOccurrence of Mycotoxins in Fish Feed and Its Effects: A Review
Plant-based ingredients have been successfully replacing fishmeal in finished fish feeds. However, using crops in feeds results in an increased risk of contamination by fungi and mycotoxins and a higher incidence of mycotoxicosis in fish. This might decrease aquaculture’s productivity as mycotoxicosis generally result in decreased body weight, growth impairment and higher rates of disease and mortality in fish. Additionally, some mycotoxins might accumulate in the fish musculature. As such, fish consumption might become another way for mycotoxins to enter the human food chain, threatening food security and public health as mycotoxins are important genotoxins, carcinogens and immunosuppressors to humans. In this work we aim to provide a review on the most important mycotoxins found in crops and in finished fish feed, i.e., aflatoxins, fumonisins, ochratoxins, trichothecenes and zearalenone. We present their effects on the health of fish and humans and their regulations in the European Union. Although work has been performed in mycotoxin research ever since the 1960s, a lot of information is still lacking regarding its effects. However, it is noticed that in order to use crops in aquafeed production, efforts should be made in order to monitor its contamination by mycotoxinogenic fungi and mycotoxins.
- Open Access
- 20 June 2013
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 24 (2) , 253-258
Cytology use for cervical cancer screening in Portugal: results from the 2005/2006 National Health Survey
Background: Understanding the patterns of cervical cytology use in preventive care may provide useful information for an efficient transition from opportunistic screening to organized programmes. We aimed to identify the determinants of non-use and underuse of cervical cytology in Portuguese women. Methods: As part of the fourth National Health Survey (2005/2006), 2191 women aged between 25 and 64 years were evaluated. The previous use of cervical cytology was classified as never or ever, and, among the latter, those having performed the latest cytology testing >5 years before were considered to underuse cervical cytology. We assessed the determinants of non-use and underuse through age- and education-adjusted odds ratios (ORs) and corresponding 95% confidence intervals (95% CIs). Results: Overall, 23.5% of women had never used cervical cytology and 10.7% reported underuse. This prevalence increased with age and decreased with education and income. Compared with the national mean, the lowest risk of non-use and underuse was observed in Norte (non-use: OR = 0.31, 95% CI: 0.23–0.42; underuse: OR = 0.60, 95% CI: 0.40–0.91) and the highest in Alentejo (non-use: OR = 2.33, 95% CI: 1.78–3.06; underuse: OR = 2.37, 95% CI: 1.43–3.93). Women without a private health insurance (OR = 2.65, 95% CI: 1.29–5.47), who had no doctor appointments in the preceding 3 months (OR = 2.06, 95% CI: 1.22–3.48) and those who had never performed a mammography (OR = 17.78, 95% CI: 9.09–34.78) were more likely to have never performed a cervical cytology. Conclusion: This study shows inequalities in the use of cervical cancer screening in Portugal and provides useful information for a better allocation of resources for cancer screening.
- 20 June 2013
- Published by Oxford University Press (OUP) in European Journal of Public Health
- Vol. 24 (2) , 253-258
Open AccessCytology use for cervical cancer screening in Portugal: results from the 2005/2006 National Health Survey
Background: Understanding the patterns of cervical cytology use in preventive care may provide useful information for an efficient transition from opportunistic screening to organized programmes. We aimed to identify the determinants of non-use and underuse of cervical cytology in Portuguese women. Methods: As part of the fourth National Health Survey (2005/2006), 2191 women aged between 25 and 64 years were evaluated. The previous use of cervical cytology was classified as never or ever, and, among the latter, those having performed the latest cytology testing >5 years before were considered to underuse cervical cytology. We assessed the determinants of non-use and underuse through age- and education-adjusted odds ratios (ORs) and corresponding 95% confidence intervals (95% CIs). Results: Overall, 23.5% of women had never used cervical cytology and 10.7% reported underuse. This prevalence increased with age and decreased with education and income. Compared with the national mean, the lowest risk of non-use and underuse was observed in Norte (non-use: OR = 0.31, 95% CI: 0.23–0.42; underuse: OR = 0.60, 95% CI: 0.40–0.91) and the highest in Alentejo (non-use: OR = 2.33, 95% CI: 1.78–3.06; underuse: OR = 2.37, 95% CI: 1.43–3.93). Women without a private health insurance (OR = 2.65, 95% CI: 1.29–5.47), who had no doctor appointments in the preceding 3 months (OR = 2.06, 95% CI: 1.22–3.48) and those who had never performed a mammography (OR = 17.78, 95% CI: 9.09–34.78) were more likely to have never performed a cervical cytology. Conclusion: This study shows inequalities in the use of cervical cancer screening in Portugal and provides useful information for a better allocation of resources for cancer screening.